The Effect of Thalidomide on Entero-Behcet's Disease |
Kim, Jung Hak
(Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Nam, Voki (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) Moon, Ho Sik (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) Kim, Jin Ook (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) Sung, Choon Ho (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) |
1 | Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 1999; 341: 1284-91 DOI ScienceOn |
2 | Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T: Intestinal involvement in Behcet's disease:review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 1981; 24: 103-6 DOI ScienceOn |
3 | Kotter I, Durk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M: Therapy of Behcet's disease. Ger J Ophthalmol 1996; 5: 92-7 PUBMED ScienceOn |
4 | Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965; 6: 303-6 DOI |
5 | Lee CK, Kim HJ: Pathogenesis and Treatment of Intestinal Behcet's disease. Korean J Gastroenterol 2007; 50: 3-8 |
6 | Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH: HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19(Suppl): 31-5 |
7 | Hamza MH: Treatment of Behcet's disease with thalidomide. Clin Rheumatol 1986; 5: 365-71 DOI PUBMED ScienceOn |
8 | Dilsen N: History and development of Behcet's disease. Rev Rhum Engl Ed 1996; 63: 512-9 PUBMED ScienceOn |
9 | Eglin RP, Lehner T, Subak-Sharpe JH: Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982; 2: 1356-61 DOI PUBMED ScienceOn |
10 | Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G: Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80 DOI PUBMED ScienceOn |
11 | Yoshikawa K, Kotake S, Sasamoto Y, Ohno S, Matsuda H: Close association of Streptococcus sanguis and Behcet's disease. Nippon Ganka Gakkai Zasshi 1991; 95: 1261-7 PUBMED |
12 | Saylan T, Saltik I: Thalidomide in the treatment of Behcet's syndrome. Arch Dermatol 1982; 118: 536 DOI ScienceOn |
13 | Houman MH, Hamzaoui K: Promising new therapies for Behcet's disease. Eur J Intern Med 2006; 17: 163-9 DOI ScienceOn |
14 | Larsson H: Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217). J Intern Med 1990; 228: 405-7 DOI PUBMED ScienceOn |
15 | Chang HK: Treatment of Behcet's disease. J Korean Rheum Assoc 2003; 10: 101-10 |
16 | Whitehead R, Gratama S: Gastrointestinal and esophageal pathology. 2nd ed. New York, Churchill Livingstone. 1995, pp 687-709 |
17 | Pacor ML, Biasi D, Lunardi C, Cortina P, Caramaschi P, Girelli D, et al: Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 1994; 13: 224-7 PUBMED |
18 | Suzuki Kurokawa M, Suzuki N: Behcet's disease. Clin Exp Med 2004; 4: 10-20 DOI ScienceOn |